Brookline Capital Acquisition Corp Schedules Shareholder Meeting on July 27, 2022 to Vote for Business Combination with Apexigen - BCAC BCACW. The Brookline Brief Contact 280 Park Avenue, Suite 43W New York, NY, 10017 T +1 646 643-6716 www.brooklinecapitalacquisitioncorp.com Sector Financial. Brookline Capital Acquisition Corp is primarely in the business of blank checks. Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. Purpose . Our greatest source of pride is the success and longevity of our clients as they grow and flourish. Create real-time notifications to follow any changes in the live stock price. Employer incorporation . Brookline Capital Acquisition Corp - Company Profile and News - Bloomberg Markets Company profile page for Brookline Capital Acquisition Corp including stock price, company news, press releases,. | July 5, 2022 The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Brookline Capital Acquisition Corp. (NASDAQ:BCAC - Get Rating. Spka moe poszukiwa moliwoci przejcia w dowolnej . View the BCAC U.S. Securities and Exchange Commission reporting information. BROOKLINE CAPITAL ACQUISITION CORP. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq . 1 (the "Amendment") to the Business Combination Agreement dated as of March 17, 2022 among BCAC, Project Barolo Merger Sub, Inc., a Delaware corporation, and Apexigen, Inc., a Delaware corporation (the "Business Combination Agreement"), in order to increase . Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. News Brookline Capital Acquisition Corp. No significant news for BCAC in the past two years. Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. Annual Meeting . Analyze Brookline Capital Return on Average Assets. BCAC's market cap has decreased by -6.88% in one year. Official Data Partner. Spka zostaa utworzona w celu przeprowadzenia fuzji, wymiany kapitaowej, przejcia aktyww, zakupu akcji, reorganizacji lub podobnego poczenia biznesowego z jednym lub wiksz liczb podmiotw. Get Brookline Capital Acquisition Corp. (BCAC:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Brookline Capital Acquisition Corp. does not have significant operations. BROOKLINE CAPITAL ACQUISITION CORP. : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share BROOKLINE CAPITAL . It was formed for the purpose of entering into a merger . Off-Balance Sheet Arrangement of a Registrant. Values delayed up to 15 minutes. I. Capital Com Australia Limited Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization,. Confirms Receipt of Sponsor Funds to Extend Period of Time to Consummate Business Combination and for Additional Working Capital 4/25/2022 Apexigen to Host Investor Day to Provide an Overview of its Antibody Therapeutic Pipeline and Unique APXiMAB Platform on Monday, May 16, 2022 3/18/2022 Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. I Shareholders Approve Extension from July 11, 2022 to August 11, 2022 and up to 5 additional one month extensions until January 11, 2023 . It is formed for the purpose of effecting into a merger . Brookline Capital Acquisition Corp is affiliated with Brookline Capital Markets, a boutique investment bank with extensive experience providing capital markets and advisory services to public and private life sciences, Special Purpose Acquisition Companies ("SPACs"), and other emerging growth enterprises. Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. Brookline Capital Acquisition Corp. SEC filings breakout by MarketWatch. New York, NY, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Brookline Capital Acquisition Corp. (NASDAQ: BCACU) (the "Company") announced today that, commencing February 22, 2021, holders of the 5,750,000.

It is formed for the purpose of effecting into a merger . A high-level overview of Brookline Capital Acquisition Corp. Units (BCACU) stock. Company profile page for Brookline Capital Acquisition Corp including stock price, company news, press releases, executives, board members, and contact information Conference Call Information. The Company will furnish without charge to each stockholder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof of the Company and the qualifications, limitations, or restrictions of such preferences and/or rights. It was formed for the purpose of entering into a merger . Brookline Capital Acquisition Corp. does not have significant operations. It is formed for the purpose of effecting into a merger . Vickers Vantage Corp. Vickers Vantage Corp. Brookline Capital Return on Average Assets are projected to increase slightly based on the last few years of reporting. Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington,. Brookline Capital Acquisition Corp Schedules Shareholder Meeting on July 27, 2022 to Vote for Business Combination with Apexigen - BCAC BCACW. For financial reporting, their fiscal year ends on December 31st. Stock analysis for Brookline Capital Acquisition Corp (BCACU:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Click here to read the Brookline Capital Acquisition Corp. 2022 Special Meeting Proxy Statement in Adobe Portable Document Format (PDF).

The past year's Return on Average Assets were at -0.0072. Mountain Crest Acquisition III: 69.73M: First US Bancshares: 65.31M . sec.gov/Archiv. Brookline Capital. . Upon closing of the transaction, Brookline Capital Acquisition Corp. will be renamed Apexigen, Inc. (the "Combined Company") and will be led by Xiaodong Yang, M.D., Ph.D., President and Chief. BCAC has a market cap or net worth of $68.54 million as of July 2, 2022, making it the 5,244th biggest public company in the US. com is a great place to look for and post law firm job listings IIB 111th CONGRESS 1st Session H The US-based broker and clearing house first revealed its intention for the acquisition in late February after receiving approval from the board of both the companies (Nasdaq: SSNC), today introduced results from the Q1 2021 issue of Joe Tsai, Executive Vice . Get the latest info and learn more about Brookline Capital Acquisition Corp.(BCAC) capital.com.

0.00%. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company; 2022-05-17: Glazer Capital LLC: 278,732 Apexigen and Brookline Capital Acquisition Corp. will host a conference call today, Friday, March 18, 2022, at 8:30 a.m. Eastern Time, to discuss the proposed . . SAN CARLOS, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. ("Apexigen"), a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer. The Audit Committee (the "Committee") of the Board of Directors (the "Board") of Brookline Capital Acquisition Corp., a Delaware corporation (the "Company"), shall provide assistance to the Board in fulfilling its legal and fiduciary obligations to oversee: It is formed for the purpose of effecting into a merger . Brookline Capital Acquisition Corp. does not have significant operations. Continental Stock Transfer & Trust Company 1 State Street 30th Floor New York, NY 10004-1561 Domestic: 212-509-4000 International: +1-212-509-4000 www . BCAC has a market cap or net worth of $68.54 million as of July 2, 2022, making it the 5,244th biggest public company in the US. It is formed for the purpose of effecting into a merger . Shareholder Meeting. Brookline Capital Acquisition Corp. Item 8.01 Other Events. As of Jun 23 2022. Brookline Capital Acquisition Corp. does not have significant operations. For financial reporting, their fiscal year ends on December 31st.

Brookline Capital Acquisition Corp. is a blank check company. Brookline Capital Acquisition Corp (Nasdaq: BCAC) Overview Brookline Capital Acquisition Corp ("BCAC") is a Nasdaq- Listed SPAC that completed a $57.5M IPO on January 29, 2021 BCAC is sponsored by Brookline Capital Markets, a division of Arcadia Securities LLC, a boutique healthcare investment bank 3 BCAC Competitive Advantages

Contact - Brookline Capital Acquisition Corp Contact BCAC@brooklinecapmkts.com (646) 603-6716 600 Lexington Avenue Floor 33 New York, NY 10022 Loading. Patrick A. Sturgeon - CFO of Brookline Capital Acquisition Corp. Patrick A. Sturgeon, our Chief Financial Officer since inception, has nearly two decades of experience with M&A and equity capital market transactions in the healthcare and other sectors. It intends to acquire companies in the life sciences sector. BROOKLINE CAPITAL ACQUISITION CORP. (Exact name of Registrant as specified in its charter) Delaware 001-39488 85-1260244 (State or other jurisdiction of (Commission (I.R.S. USD . A high-level overview of Brookline Capital Acquisition Corp. Units (BCACU) stock. USD . New York, NY, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Brookline Capital Acquisition Corp. (NASDAQ: BCACU) (the "Company") announced today that it closed its initial public offering of 5,750,000 . This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K . Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. View today's Brookline Capital Acquisition Corp stock price and latest BCACU news and analysis. WALLEYE CAPITAL LLC Bought 18.9 Thousand shares of Brookline Capital Acquisi. trading higher 10.19 USD. New York, NY, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Brookline Capital Acquisition Corp. (NASDAQ: BCACU) (the "Company") announced today that, commencing February 22, 2021, holders of the 5,750,000 . sec.gov/Archiv. Brookline Capital Acquisition stock opened at $10.17 on Wednesday. As previously disclosed, on May 2, 2022, Brookline Capital Acquisition Corp., a Delaware corporation (the "Company"), issued a non-convertible unsecured promissory note (the "Extension Note") in the principal amount of to Get the latest info and learn more about Brookline Capital Acquisition Corp.(BCAC) capital.com. Company Description. Click here to vote your proxy online. Brookline Capital Acquisition Corp. (BCAC:NAQ) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. Brookline Capital Acquisition Corp. (the "Company") previously disclosed in our Notification of Late Filing on Form 12b-25 filed with the SEC on November 15, 2021 that the compilation . The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. Brookline Capital Acquisition Corp. (Exact name of registrant as specified in its charter) _____ Delaware 6770 85-1260244 (State or other jurisdiction of . I Shareholders Approve Extension from July 11, 2022 to August 11, 2022 and up to 5 additional one month extensions until January 11, 2023 . Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. --Brookline Capital Acquisition Corp. announced today that it closed its initial public offering of 5,750,000 units, including the exercise in full of the underwriters' 45- day option to . Brookline Capital Acquisition Corp. BCACU.OQ. Company profile page for Brookline Capital Acquisition Corp including stock price, company news, press releases, executives, board members, and contact information It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the life sciences industry. Brookline Capital Acquisition Corp is primarely in the business of blank checks. Find company research, competitor information, contact details & financial data for Brookline Capital Acquisition Corp. of New York, NY. Latest Trade. Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. Fondamentaux, dividendes, donnes financires et analyse de Brookline Capital Acquisition Corp It is formed for the purpose of effecting into a merger . brookline capital acquisition corp. is a blank check company, also commonly referred to as a special purpose acquisition company, or spac, formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or He has served as a Managing Director at Brookline Capital Markets, since 2016. Search: Miles Capital Acquisition. AUDIT COMMITTEE CHARTER . The company's fifty day moving average price is $10.13 and its 200 day moving average price is $10.07. Brookline Capital Acquisition Corp. Common Stock (BCAC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company; 2022-05-17: Glazer Capital LLC: 278,732 It is formed for the purpose of effecting into a merger . Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-0.37 Market Cap $68.54 M Shares Outstanding 6.75 M Public. Brookline Capital Acquisition Corp. jest spk typu "blank check". BROOKLINE CAPITAL ACQUISITION CORP. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Brookline Capital Acquisition Corp.. Shareholder Meeting. The company was founded in 2020 and is based in . Brookline Capital Acquisition Corp is a blank check company. Change 0 % Change. View the latest Brookline Capital Acquisition Corp. (BCAC) stock price, news, historical charts, analyst ratings and financial information from WSJ. 3/31/2022 WOLVERINE ASSET MANAGEMENT LLC Bought 8.4 Thousand shares of Brookline Capital Acquisi. Find the latest Brookline Capital Acquisition Corp. (BCACW) stock quote, history, news and other vital information to help you with your stock trading and investing. The Company will furnish without charge to each unitholder who so requests, a statement of the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof of the Company and the qualifications, limitations, or restrictions of such preferences and/or rights. New York, NY, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Brookline Capital Acquisition Corp. (NASDAQ: BCACU) (the "Company") announced today that, commencing February 22, 2021, holders of the 5,750,000 . It is formed for the purpose of effecting into a merger . BROOKLINE CAPITAL ACQUISITION CORP. References to the "Company," "Brookline Capital Acquisition Corp.," "Brookline," "our," "us" or "we" refer to Brookline Capital Acquisition Corp.The following discussion and analysis of the Company's financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this report. Exhibit 99.1 . On June 26, 2022, Brookline Capital Acquisition Corp., a Delaware corporation ("BCAC"), entered into Amendment No. Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. Brookline is recognized for its differentiated ability to source capital from traditional institutional investors, as well as from its proprietary network of global family offices and high net worth investors.

The business has a 50 day moving average of $10.09 and a two-hundred day moving . Brookline Capital Acquisition Corp. is incorporated in the state of Delaware. Mountain Crest Acquisition III: 69.73M: First US Bancshares: 65.31M . Shares of BCAC stock opened at $10.11 on Tuesday. Brookline Capital Acquisition Corp. Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an. Get the latest business insights from Dun & Bradstreet. The Company may pursue an acquisition opportunity in any industry or sector, it intends . This certificate and the shares . . It intends to acquire companies in the life . Capital Com Australia Limited Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) BCAC's market cap has decreased by -6.88% in one year. Brookline Capital Acquisition Corp. (the "Company") is a newly organized blank check company incorporated in Delaware and formed for the purpose of effecting a merger, share e Brookline Capital Acquisition Corp. is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of entering into a merger, share . .